Vera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	25.09	45.68	43.46	79.67	53.65	3.2
Short-Term Investments	359.3	115.04	71.19	-	0.09	0.03
Cash & Short-Term Investments	384.39	160.72	114.65	79.67	53.74	3.23
Cash Growth	112.34%	40.18%	43.90%	48.26%	1564.29%	-
Other Receivables	1.96	-	-	-	0.05	-
Receivables	1.96	-	-	-	0.05	-
Prepaid Expenses	7.97	8.09	10.33	2.38	0.03	0.33
Restricted Cash	-	-	-	-	0.05	-
Other Current Assets	0.43	3.22	0.72	0.48	0.39	0
Total Current Assets	394.75	172.02	125.7	82.54	54.26	3.57
Property, Plant & Equipment	2.08	3.04	5.22	-	-	1.39
Long-Term Investments	-	0.01	0.06	0.87	-	-
Other Long-Term Assets	0.46	0.47	0.46	0.34	0.29	0.42
Total Assets	397.29	175.55	131.44	83.75	54.55	5.38
Accounts Payable	4.66	11.12	11.99	1.39	0.91	0.34
Accrued Expenses	11.64	8.75	10.96	5.93	0.54	0.38
Current Portion of Leases	2.12	2.44	2.65	-	-	0.12
Other Current Liabilities	-	-	-	0.38	0.96	0.22
Total Current Liabilities	18.42	22.3	25.6	7.69	2.41	1.06
Long-Term Debt	50.26	49.88	24.81	4.92	-	-
Long-Term Leases	0.46	1.4	3.83	-	-	0.01
Other Long-Term Liabilities	0.29	0.29	0.29	1.54	1.92	0.76
Total Liabilities	69.42	73.86	54.53	14.16	4.33	1.83
Common Stock	0.06	0.04	0.03	0.02	-	-
Additional Paid-In Capital	699.46	410.49	290.22	193.63	2.1	1.49
Retained Earnings	-371.19	-309.1	-213.11	-124.06	-91.45	-38.03
Comprehensive Income & Other	-0.45	0.25	-0.22	-	-	-
Total Common Equity	327.87	101.69	76.91	69.59	-89.35	-36.55
Shareholders' Equity	327.87	101.69	76.91	69.59	50.23	3.55
Total Liabilities & Equity	397.29	175.55	131.44	83.75	54.55	5.38
Total Debt	52.83	53.71	31.29	4.92	-	0.13
Net Cash (Debt)	331.55	107.01	83.37	74.75	53.74	3.1
Net Cash Growth	119.68%	28.36%	11.53%	39.10%	1635.23%	-
Net Cash Per Share	6.82	2.51	3.14	5.56	167.96	10.49
Filing Date Shares Outstanding	54.83	54.45	44.26	27.05	0.36	0.3
Total Common Shares Outstanding	54.82	44.45	27.8	21.28	0.36	0.3
Working Capital	376.33	149.72	100.1	74.85	51.86	2.51
Book Value Per Share	5.98	2.29	2.77	3.27	-251.47	-123.75
Tangible Book Value	327.87	101.69	76.91	69.59	-89.35	-36.55
Tangible Book Value Per Share	5.98	2.29	2.77	3.27	-251.47	-123.75
Machinery	-	-	-	-	-	1.06
Leasehold Improvements	-	-	-	-	-	0.42

Source: S&P Capital IQ. Standard template. Financial Sources.